Varicella-zoster virus meningitis during amenamevir therapy with measured cerebrospinal fluid drug concentration: A case report
Journal of Family Medicine and Primary Care · 2026-06 · 15 (6) · 2338-2340
DOI: 10.4103/jfmpc.jfmpc_473_26 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Family Medicine and Primary Care, online erschienen am 27.07.2026. Verfasst von Rina Matsumoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care and Emergency Medicine, National Hospital Organization Yokohama Medical Center, Yokohama City, Kanagawa, Japan. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Varicella-zoster virus (VZV) meningitis has been reported during treatment with amenamevir (AMNV). Although case reports have raised concerns about its ability to prevent central nervous system (CNS) complications, cerebrospinal fluid (CSF) penetration has not been evaluated. We report the first case of VZV meningitis with measured CSF AMNV concentration. An 80-year-old man developed altered consciousness and dysarthria on day 7 of AMNV therapy for thoracic herpes zoster. The CSF AMNV concentration on admission was 0.086 µmol/L (41.3 ng/mL), measured 20–24 h after the last dose, within the reported in vitro half-maximal effective concentration (EC 50 ) range for VZV (0.055–0.10 µmol/L) in Japan; however, the clinical relevance of this comparison remains uncertain. The patient’s condition improved rapidly after initiation of acyclovir therapy. This case provides the first direct evidence that AMNV reaches the CSF. However, whether CSF exposure is sufficient to prevent CNS complications or attenuate disease severity remains unclear.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care and Emergency Medicine, National Hospital Organization Yokohama Medical Center, Yokohama City, Kanagawa, Japan.
Zitieren
APA
Matsumoto, R., Horiuchi, H., Otsuka, T., Miyazaki, H., & Furuya, R. (2026). Varicella-zoster virus meningitis during amenamevir therapy with measured cerebrospinal fluid drug concentration: A case report. Journal of Family Medicine and Primary Care, 15(6), 2338-2340. https://doi.org/10.4103/jfmpc.jfmpc_473_26
Vancouver
Matsumoto R, Horiuchi H, Otsuka T, Miyazaki H, Furuya R. Varicella-zoster virus meningitis during amenamevir therapy with measured cerebrospinal fluid drug concentration: A case report. Journal of Family Medicine and Primary Care. 2026;15(6):2338-2340. doi:10.4103/jfmpc.jfmpc_473_26
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Rina and Horiuchi, Hiroshi and Otsuka, Tsuyoshi and Miyazaki, Hiroshi and Furuya, Ryosuke},
title = {Varicella-zoster virus meningitis during amenamevir therapy with measured cerebrospinal fluid drug concentration: A case report},
journal = {Journal of Family Medicine and Primary Care},
year = {2026},
volume = {15},
number = {6},
pages = {2338--2340},
doi = {10.4103/jfmpc.jfmpc_473_26}
}
EUVIMED